Description: Fusen Pharmaceutical Company Limited, an investment holding company, manufactures and sells pharmaceutical products in the People's Republic of China. The company's product portfolio includes Shuanghuanglian-based cold medicines comprising Shuanghuanglian oral solutions and Shuanghuanglian injections; and flunarizine hydrochloride capsules and compound ferrous sulfate granules, as well as Yuanhu Zhitong oral solutions, Ganweikang tablets, and Yixinkang tablets. In addition, it researches, develops, produces, and sells various proprietary Chinese medicines and western medicine products for the treatment of cold and fever, cardiovascular diseases, and anemia. Further, the company offers business management and consulting services. Fusen Pharmaceutical Company Limited was founded in 2003 and is headquartered in Nanyang, China.
Home Page: www.fusenyy.com
Urban Industrial Zone
Nanyang,
China
Phone:
Officers
| Name | Title |
|---|---|
| Mr. Changcheng Cao | Exec. Chairman |
| Mr. Zhiming Cao | CEO & Exec. Director |
| Mr. Taisheng Hou | Exec. Director |
| Mr. Yongsheng Chi | Exec. Director |
| Ms. Qingfen Meng | Exec. Director |
| Mr. Zhen Li | Chief Financial Officer |
| Mr. Tik Man Wong | Company Sec. |
Exchange: HK
Country: HK : Hong Kong
Currency: Hong Kong Dollar (HK$)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 66.5 |
| Price-to-Book MRQ: | 1.1642 |
| Price-to-Sales TTM: | 3.3077 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 1143 |